V5626
Val-Tyr
>98% (TLC), suitable for ligand binding assays
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Empirical Formula (Hill Notation):
C14H20N2O4
CAS Number:
Molecular Weight:
280.32
MDL number:
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.26
Recommended Products
Product Name
Val-Tyr,
Assay
>98% (TLC)
form
powder
technique(s)
ligand binding assay: suitable
color
white to off-white
storage temp.
−20°C
SMILES string
OC([C@@H](NC([C@@H](N)C(C)C)=O)CC1=CC=C(O)C=C1)=O
InChI
1S/C14H20N2O4/c1-8(2)12(15)13(18)16-11(14(19)20)7-9-3-5-10(17)6-4-9/h3-6,8,11-12,17H,7,15H2,1-2H3,(H,16,18)(H,19,20)
InChI key
VEYJKJORLPYVLO-UHFFFAOYSA-N
Storage Class Code
13 - Non Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Regulatory Information
新产品
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Mitsuru Tanaka et al.
Bioscience, biotechnology, and biochemistry, 70(9), 2292-2295 (2006-09-09)
In this study, we found that antihypertensive di-peptide Val-Tyr (VY) showed a vascular relaxation effect in KCl-induced contraction of thoracic aorta rings from 18-week-old spontaneously hypertensive rats among di-peptides of VY, Ile-Tyr, and Tyr-Val irrespective of their angiotensin I-converting enzyme
Takao Ueno et al.
Analytical sciences : the international journal of the Japan Society for Analytical Chemistry, 21(8), 997-1000 (2005-08-27)
A double column-switching HPLC method with naphthalene-2,3-dialdehyde (NDA) was applied for determination of two plasma antihypertensive peptides, Val-Tyr (VY) and Ile-Val-Tyr (IVY). After a first separation on a Phe-ODS column, double heart-cuts of the retention time corresponding to NDA-VY and
Jocksan I Morales-Camacho et al.
Applied microbiology and biotechnology (2018-09-14)
The insertion of peptides is a biotechnology tool widely used to improve the nutraceutical properties of proteins. Because the effect of these insertions in protein stability and function is difficult to predict, it should be determined experimentally. In this study
Toshiro Matsui et al.
Life sciences, 79(26), 2492-2498 (2006-09-09)
Some di-peptides have been proven to exert an antihypertensive effect in mild-hypertensive subjects. The aim of this study was to clarify whether combined administration of an ACE inhibitor, captopril, with an antihypertensive di-peptide Val-Tyr (VY) would alter their potent antihypertensive
Spectroscopic and structural elucidation of L-tyrosine-containing dipeptides valyl-tyrosine and tyrosyl-alanine: solid-state IR-LD spectroscopy, quantum chemical calculations and vibrational analysis.
Koleva BB, Kolev TM, Spiteller M.
Spectrochimica Acta Part A: Molecular Spectroscopy, 68, 1187-1196 (2007)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service